In europe, this eggplant is known as “benadona” (meaning “pretty lady”), with its fruit of purple and poisonous fruit, and its leaf hides deadly bioalkalin. However, it is this very toxic plant, which was used to make poison arrows and court assassinations, that, after hundreds of years of pharmacological exploration, has finally become the classic drug in modern clinical defusing muscle spasms — the spinach. Its research and development has brought together humans' domestication wisdom of natural toxicity and has further demonstrated the cross-cutting development from empirical medicine to precision treatment。
I. Traditional traditions: a cognitive revolution from “venomous herbs” to “solved pharmacists”
The drug history of the argon can be traced back to the ancient greek period, but true systematic research began in europe in the sixteenth century. At that time, the italian physician pedro andrea martini, who for the first time recorded his “screech pupils” character in the botanical log, found that his juices could expand the pupils, a phenomenon that had been used to treat eye inflammation but had also led to the blindness of patients due to the uncontrolled dose. In the 19th century, the german chemist ledenberg separated the alkalin from the arctic and synthesized its derivative atropine, revealing the central mechanism of its resistance to choline performance. - dismantling smooth muscle spasms by disrupting the combination of acetylcholine and m receptors and inhibiting leopardism。
This finding has completely changed the medical status of the halo. In 1880, ledenberg used atropine to treat organophosphorus poisoning and found that choline caused by its antitoxicants was overexcited and saved countless lives. At the beginning of the twentieth century, the bellow formulation was introduced into china as an important drug for treating diseases of the digestive system. For example, in the 1930s, a tussack plaster produced by the rayon pharmaceutical plant in shanghai had been used to alleviate the acupuncture caused by stomach ulcers, the efficacy of which was validated in the clinical report of the chinese medical journal。
Scientific decodement: precision treatment from single ingredient to combination
The core active components of the arctic tablets, which are synergized through different mechanisms, are radon and ortholine:
1. Plasma: the main function is gastrointestinal smoothing muscles, which reduce muscle tension by blocking the m receptor and relieve convulsive pain. Clinical data show a 30 per cent increase in the emptiness of the stomach after oral exposure to 20mg cortex, a 40 per cent reduction in the frequency of cortex creeping, and a significant reduction in post-eat pain for ulcer patients。
2. Ethylene: a combination of central inhibitions can reduce gland secretion (e. G. Saliva, sweat) and the vomiting caused by a leaching nerve reflection. This characteristic makes it a common drug for eye-scathed pupils, which can expand to 8 mm in 15 minutes and is reversible。
To enhance the efficacy of treatment and reduce the side effects, the modern research and development team explored a combination of formulation strategies:
• continent tablets + non-inflammatory drugs (nsaids): for patients with renal acupuncture, the arctic tablets mitigate urethrosis and sodium bichlorfonate inhibition of prostate synthesis, which together increase pain relief from 58 per cent to 82 per cent。
• plasma + prophyxia: in functional diarrhoea treatment, the cortex inhibits intestine creeping, bicoccus regulates the herd balance, 90 per cent abdominal pain relief after three months, and 85 per cent improvement in feces。
• continent + inhaled sugar cortex hormones: for chronic obstructive pulmonary disease (copd) acute stress periods, as well as for the reduction of gasdoctrines, the suppression of inflammation response in budined, and coordinated improvement of lung function。
Iii. Technological breakthroughs: agent-type innovations, ranging from coarse leaching to nanomaterials
The traditional halibut tablets are based on ablution, with such deficiencies as low bioavailability (30-40 per cent), slow performance (1-2 hours). To address these challenges, the r & d team achieved agent-type upgrading through the following technologies:
1. Nanocrystal agent: use of high-pressure parity technology to make bialkalis of the argon into nanoparticles (particle sizes)
2. Leather penetrators: plasma bioalkali orientation to the abdomen skin through lipid packaging technology to avoid the first liver effects. Clinical studies have confirmed that perforation can last 24 hours and reduce the incidence of side effects such as constipation and mouth drying by 60 per cent。
3. Smartly controlled tablets: use of hydropropyl cellulose skeleton material to achieve the release of drugs at the gradient of the gastrointestinal tract. For example, a 12-hour slow release film developed by an enterprise can reduce the volatility of blood drug concentrations from 300 per cent of traditional tablets to 50 per cent, significantly increasing patient dependence。
Clinical values: from single disease to multidisciplinary application
The research and development of the aroma film was originally intended to mitigate smooth muscle spasms, but its clinical application has been extended to a number of areas:
1. Diseases of the digestive system: they continue to be core ailments, covering stomach ulcer, intestinal irritation syndrome (ibs) and galling. For example, in ibs treatments, co-polymphommonium diazole can reduce abdominal pain rates by 70 per cent and the back-up rate of urination by 85 per cent。
2. Pain management: the choline can be transmitted by inhibiting anal neurological dysentery, and the argon is used for nervous pains such as trident neurological pains and post-grass rash rashes. The use of opioids can be reduced by 30 per cent and the risk of addiction。
3. Special scenario-aided medicines: in the ophthalmology, the ashtray is used for iris hysteria screening; in the urology surgery, it is used in conjunction with m receptors to enhance the efficacy of the treatment of bladder hyperactivity disorder (oab)。
Security challenges: from empirical drug use to precision control upgrading
Despite the accuracy of the arctic tablets, their resistance to choline side effects (e. G. Drying, constipation, blurred vision) still requires strict control. The r & d team promoted drug safety through the following strategies:
1. Guidance medicine for genetic testing: the study found that patients with slow-synthesis cyp2d6 genes were three times higher in blood than normal metabolisms and were vulnerable to adverse reactions, following the use of spinach tablets. In the future, the screening of populations for application through genetic testing can reduce the incidence of side effects by 50 per cent。
2. Smart drug alert system: a combination of wearable equipment to monitor patient heart rate, blood pressure change, ai algorithm to provide real-time warning of adverse reaction risk. For example, an enterprise has developed a “atoric tablet management system” that has increased patient dependence to 95 per cent。
3. Low-dose formulation development: for older patients, 5 mg low-dose tablets have been developed to reduce the incidence of adverse effects such as constipation and urine retention from 15 per cent to 5 per cent。
Vi. Looking ahead: from classic drugs to the poles of modern precision treatment
The research and development of the arctic film confirms the innovative concept of “natural drugs and chemical synthesis”. As pharmaceutical technology advances, its direction will focus on three main areas:
Target delivery systems: use nanotechnologies to accurately deliver drugs to pathological tissues to reduce overall exposure。
Individualized treatment: customizing the dose with the patient's genetic and metabolic characteristics to achieve “one side”。
3. Joint therapy innovation: exploring synergies with prophylactic bacteria, neuroregulators and expanding applications in the areas of functional gastrointestinal disease and chronic pain。
From ancient greek “venomous herbs” to modern decompressants, the history of the development of the aroma is an epic of humans taming nature and breaking scientific boundaries. In the future, this classic drug will continue to be innovative in providing safer and more accurate treatments for patients worldwide。
